top of page
CGTI.png

Thomas Potgieter

SVP of Global Cell Therapy Development & Operations at Bristol Myers Squibb

​

Share
  • LinkedIn
  • Youtube
  • X
  • Instagram
How we drive innovation
STORIES
MEETINGS
MEMBERS
Speakers

Uwe Gottschalk

Uwe Gottschalk is Chief Scientific Officer (CSO) at Lonza since July 2017. Between 2014 and 2017 he served as a Chief Technology Officer where he established and led the global Research and Technology organisation of Lonza Pharma/Biotech.

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Jesse McCool

CSO of Bionova Scientific

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Angela Vollstedt, PhD MBA

Director Global Cell & Gene Therapies Portfolio Management at Novartis

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Paolo Martini

Chief Research & Development Officer at ReAlta Life Sciences former CSO at Moderna

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Gwendolyn Binder PhD

President, Science and Technology at Cabaletta Bio

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Warner Biddle

CEO at Kyverna Therapeutics former interim CEO at Kite a Gilead Company

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS
bottom of page